GO:0006090 pyruvate metabolic process: Energy Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006090 pyruvate metabolic process describes all chemical reactions and pathways involving pyruvate (2-oxopropanoate), the end product of glycolysis and a central metabolic node.
• Pyruvate sits at the crossroads of energy production, gluconeogenesis, amino acid metabolism, and fermentation, linking cytosolic glycolysis to mitochondrial oxidative phosphorylation [1,5].
• Key enzymes include pyruvate dehydrogenase complex (PDHC), pyruvate kinase (PK), lactate dehydrogenase (LDH), and pyruvate carboxylase (PC), whose activities are tightly regulated [1,3,5].
• Dysregulation of pyruvate metabolism is implicated in mitochondrial disorders, cancer (Warburg effect), and metabolic diseases, making it a therapeutic target [3,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of pyruvate metabolic genes in disease contexts [1,5].
• Studying pyruvate metabolic process requires integrated methods: metabolic flux analysis, enzyme assays, and CRISPR screening to identify causal genes [1,3,5].
Description
Pyruvate metabolic process (GO:0006090) encompasses the chemical reactions and pathways involving pyruvate, the three-carbon alpha-keto acid that serves as a pivotal metabolite in cellular energy metabolism. Pyruvate is the end product of glycolysis and can be further oxidized to acetyl-CoA for the tricarboxylic acid (TCA) cycle, reduced to lactate under anaerobic conditions, or carboxylated to oxaloacetate for gluconeogenesis [1,5]. This process is essential for maintaining metabolic homeostasis and is conserved across prokaryotes and eukaryotes, from lactic acid bacteria to humans [6,7]. Researchers study pyruvate metabolism to understand fundamental bioenergetics, mitochondrial function, and the metabolic reprogramming that occurs in diseases such as cancer and mitochondrial disorders [3,8]. The pyruvate dehydrogenase complex (PDHC) catalyzes the irreversible oxidative decarboxylation of pyruvate to acetyl-CoA, a rate-limiting step that links glycolysis to the TCA cycle [1,3]. Regulation of PDHC by pyruvate dehydrogenase kinases (PDKs) and phosphatases allows fine-tuning of fuel selection in response to energy demands. In addition, pyruvate kinase (PK) controls the final step of glycolysis, and its inhibition by oxalate alters hepatic metabolism, highlighting the tight regulation of pyruvate flux. Given its central role, pyruvate metabolic process is a focus for therapeutic intervention in metabolic and neoplastic diseases.
pyruvate metabolic process At A Glance
| GO ID | GO:0006090 |
|---|---|
| GO term | pyruvate metabolic process |
| Ontology | biological_process |
| Synonym | pyruvate dehydrogenase bypass; pyruvate metabolism |
| Major function | Central carbon metabolism: conversion of pyruvate to acetyl-CoA, lactate, oxaloacetate, or alanine |
| Key enzymes | Pyruvate dehydrogenase complex (PDHC), pyruvate kinase (PK), lactate dehydrogenase (LDH), pyruvate carboxylase (PC), alanine aminotransferase (ALT) |
| Subcellular locations | Cytosol and mitochondrion |
| Related pathways | Glycolysis, TCA cycle, gluconeogenesis, amino acid metabolism, fermentation |
| Disease relevance | Mitochondrial disorders, cancer, metabolic syndromes |
What Is GO:0006090?
According to the Gene Ontology, pyruvate metabolic process (GO:0006090) is defined as the chemical reactions and pathways involving pyruvate, 2-oxopropanoate. This includes the synthesis, utilization, and interconversion of pyruvate through enzymatic steps such as decarboxylation, reduction, transamination, and carboxylation. The term also encompasses the pyruvate dehydrogenase bypass, a pathway that generates acetyl-CoA without the PDHC in some organisms [6,7].
Why Is pyruvate metabolic process Important in Cell Biology?
Pyruvate metabolic process is fundamentally important because it serves as the metabolic hub connecting glycolysis, the TCA cycle, and gluconeogenesis, thereby influencing cellular energy production and biosynthetic precursor supply [1,5]. Its dysregulation is associated with mitochondrial diseases, where impaired PDHC activity leads to lactic acidosis and neurological deficits [3,8]. In cancer, the Warburg effect shifts pyruvate metabolism toward lactate production, supporting rapid proliferation. Understanding this process is therefore critical for developing therapies targeting metabolic reprogramming.
• Pyruvate is the end product of glycolysis and the primary substrate for mitochondrial oxidative metabolism.
• PDHC activity determines the flux of pyruvate into the TCA cycle, affecting ATP production [1,3].
• Pyruvate carboxylase is essential for gluconeogenesis and anaplerosis.
• Lactate dehydrogenase converts pyruvate to lactate, regenerating NAD+ for continued glycolysis under hypoxia.
• Alanine aminotransferase links pyruvate to amino acid metabolism, particularly alanine and glutamate.
• In Helicobacter pylori, pyruvate metabolism supports colonization and survival in the gastric mucosa.
• Mitochondrial disorders often involve defects in pyruvate oxidation, leading to lactic acidosis.
• The pyruvate dehydrogenase bypass is used by lactic acid bacteria for acetyl-CoA production.
• Pyruvate metabolism is a target for cancer therapy due to the Warburg effect.
• CRISPR-based models allow functional dissection of pyruvate metabolic genes in disease [1,5].
What Happens During pyruvate metabolic process?
Glycolysis and Pyruvate Generation
In simple terms: Glucose is broken down to produce pyruvate, the starting point of this process.
Glycolysis converts glucose to two molecules of pyruvate, generating ATP and NADH. Pyruvate kinase (PK) catalyzes the final step, transferring a phosphate from phosphoenolpyruvate to ADP. Inhibition of PK by oxalate in intact rat hepatocytes alters metabolic flux, demonstrating the regulatory importance of this step. In lactic acid bacteria, pyruvate is a key intermediate in carbohydrate metabolism, leading to various fermentation products.
Oxidative Decarboxylation by PDHC
In simple terms: Pyruvate is converted into acetyl-CoA, which enters the energy-producing TCA cycle.
The pyruvate dehydrogenase complex (PDHC) catalyzes the irreversible oxidative decarboxylation of pyruvate to acetyl-CoA, NADH, and CO2. This reaction links glycolysis to the TCA cycle and is essential for aerobic energy production [1,3]. PDHC activity is regulated by pyruvate dehydrogenase kinases (PDKs) and phosphatases; pyruvate itself inhibits PDK, promoting PDHC activity. In isolated human skeletal muscle mitochondria, carnitine stimulates PDHC, suggesting a role in substrate availability.
Fermentative Pathways: Lactate and Ethanol Production
In simple terms: When oxygen is scarce, pyruvate is converted to lactate or ethanol to keep energy production going.
Under anaerobic conditions, pyruvate is reduced to lactate by lactate dehydrogenase (LDH), regenerating NAD+ for glycolysis. In lactic acid bacteria, pyruvate is metabolized to lactate, acetate, ethanol, and other products, depending on the organism and conditions. In Helicobacter pylori, pyruvate metabolism includes the production of acetate and formate, which may contribute to its survival in the gastric environment.
Gluconeogenic and Anaplerotic Reactions
In simple terms: Pyruvate can be used to make glucose or replenish TCA cycle intermediates.
Pyruvate carboxylase (PC) carboxylates pyruvate to oxaloacetate, an anaplerotic reaction that replenishes TCA cycle intermediates and provides substrate for gluconeogenesis. In hepatocytes, pyruvate carboxylation is crucial for glucose production. Additionally, alanine aminotransferase (ALT) converts pyruvate to alanine, linking carbohydrate and amino acid metabolism.
Pyruvate Dehydrogenase Bypass
In simple terms: Some organisms can make acetyl-CoA from pyruvate without using the PDHC.
The pyruvate dehydrogenase bypass is an alternative route to acetyl-CoA that avoids the PDHC. In lactic acid bacteria, this bypass involves pyruvate formate-lyase or pyruvate:ferredoxin oxidoreductase, allowing acetyl-CoA production under anaerobic conditions. This pathway is also present in some pathogenic bacteria and contributes to their metabolic flexibility.
Key Genes Involved in GO:0006090 pyruvate metabolic process
The following genes and proteins are central to pyruvate metabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDHA1 | Pyruvate dehydrogenase E1 alpha subunit; catalyzes pyruvate decarboxylation | Mutations cause PDHC deficiency and lactic acidosis |
| PDHB | Pyruvate dehydrogenase E1 beta subunit | Component of PDHC; target for metabolic studies |
| DLAT | Dihydrolipoamide acetyltransferase; PDHC component | Autoantigen in primary biliary cholangitis; metabolic role |
| DLD | Dihydrolipoamide dehydrogenase; PDHC component | Defects cause E3 deficiency and mitochondrial disease |
| PDK1 | Pyruvate dehydrogenase kinase 1; inhibits PDHC | Regulated by pyruvate; target in cancer metabolism |
| PDK2 | Pyruvate dehydrogenase kinase 2 | Inhibits PDHC; isoform-specific regulation |
| PDP1 | Pyruvate dehydrogenase phosphatase 1; activates PDHC | Counteracts PDK; regulates flux |
| PKM | Pyruvate kinase M; final step of glycolysis | Inhibited by oxalate; role in cancer (PKM2) |
| PKLR | Pyruvate kinase L/R; liver and red blood cell isoforms | Deficiency causes hemolytic anemia |
| LDHA | Lactate dehydrogenase A; converts pyruvate to lactate | Target in cancer; Warburg effect |
| LDHB | Lactate dehydrogenase B | Isoform-specific roles in metabolism |
| PC | Pyruvate carboxylase; converts pyruvate to oxaloacetate | Essential for gluconeogenesis; deficiency causes lactic acidosis |
| PCK1 | Phosphoenolpyruvate carboxykinase 1; gluconeogenesis | Uses oxaloacetate from pyruvate |
| PCK2 | Phosphoenolpyruvate carboxykinase 2; mitochondrial | Gluconeogenesis and anaplerosis |
| GPT | Glutamic-pyruvic transaminase (ALT); converts pyruvate to alanine | Marker of liver function; links amino acid metabolism |
| MPC1 | Mitochondrial pyruvate carrier 1 | Imports pyruvate into mitochondria |
| MPC2 | Mitochondrial pyruvate carrier 2 | Pyruvate transport; mutations affect metabolism |
| ACACA | Acetyl-CoA carboxylase alpha; uses acetyl-CoA from pyruvate | Lipogenesis; regulated by pyruvate flux |
How Is pyruvate metabolic process Regulated?
Pyruvate metabolic process is regulated at multiple levels. The pyruvate dehydrogenase complex (PDHC) is controlled by reversible phosphorylation: pyruvate dehydrogenase kinases (PDKs) phosphorylate and inhibit PDHC, while pyruvate dehydrogenase phosphatases (PDPs) activate it. Pyruvate itself inhibits PDK, promoting PDHC activity when pyruvate is abundant. In rat heart, pyruvate directly affects PDK activity, demonstrating feedback regulation. Additionally, carnitine stimulates PDHC in human skeletal muscle mitochondria, suggesting regulation by substrate availability. Pyruvate kinase is allosterically regulated and can be inhibited by oxalate, as shown in rat hepatocytes. Hormonal and nutritional signals also influence pyruvate metabolism, but specific pathways are beyond the scope of this article.
pyruvate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDHA1 | PDHC deficiency; lactic acidosis; neurological impairment | Knockout or point mutation in cell lines; patient-derived fibroblasts |
| LDHA | Cancer; Warburg effect; tumor growth | Knockout in cancer cell lines; xenograft models |
| PKM | Cancer; metabolic reprogramming; hemolytic anemia (PKLR) | Point mutation (PKM2) or knockout; metabolic flux assays |
| PC | Pyruvate carboxylase deficiency; lactic acidosis; gluconeogenesis defects | Knockout in hepatocytes; CRISPR knock-in of patient mutations |
| MPC1/2 | Mitochondrial pyruvate transport defects; metabolic disorders | Knockout in cell lines; overexpression for rescue |
Mitochondrial Disorders and PDHC Deficiency
Defects in pyruvate metabolism, particularly in the pyruvate dehydrogenase complex (PDHC), cause mitochondrial disorders characterized by lactic acidosis, neurological impairment, and developmental delay [3,8]. Mutations in PDHA1, the most common cause of PDHC deficiency, lead to reduced acetyl-CoA production and energy failure. Therapy for mitochondrial disorders often aims to bypass the metabolic block, for example by providing alternative substrates or cofactors. Carnitine stimulation of PDHC in isolated mitochondria suggests a potential therapeutic strategy.
Cancer and the Warburg Effect
Cancer cells often reprogram pyruvate metabolism toward lactate production even in the presence of oxygen, a phenomenon known as the Warburg effect. This shift is supported by increased expression of lactate dehydrogenase A (LDHA) and pyruvate kinase M2 (PKM2), which favor fermentation and biosynthetic pathways. Targeting pyruvate metabolism, such as inhibiting LDHA or PKM2, is an active area of cancer therapeutics. The pyruvate dehydrogenase bypass may also contribute to metabolic flexibility in tumors.
Infectious Diseases and Bacterial Metabolism
Pyruvate metabolism is essential for the survival of pathogenic bacteria such as Helicobacter pylori, which colonizes the gastric mucosa. H. pylori utilizes pyruvate to produce acetate and formate, contributing to its energy metabolism and acid resistance. Lactic acid bacteria rely on pyruvate metabolism for fermentation, which is important in food production and probiotics. Understanding these pathways can inform antimicrobial strategies.
From pyruvate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PDHA1 impair oxidative metabolism? | CRISPR knockout of PDHA1 in HEK293 or HeLa cells; measure lactate and oxygen consumption |
| How does a specific point mutation in PKM affect enzyme kinetics? | CRISPR point mutation (e.g., PKM2 mutants) in isogenic cell lines; enzyme assays |
| Can wild-type PC rescue gluconeogenesis in PC-knockout cells? | CRISPR knock-in of PC cDNA or overexpression; glucose production assays |
| What is the role of LDHA in tumor growth? | LDHA knockout in cancer cell lines; xenograft mouse models |
| Does mitochondrial pyruvate carrier (MPC) overexpression alter pyruvate flux? | Overexpression of MPC1/2 in cell lines; isotope tracing |
| Can CRISPR screening identify synthetic lethal partners with PDHC loss? | Genome-wide CRISPR knockout library screening in PDHA1-knockout cells |
How to Study the pyruvate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C metabolic flux analysis | Flux of pyruvate through oxidative and fermentative pathways | Assessing PDHC activity and Warburg effect [1,5] |
| PDHC enzyme assay | NADH production from pyruvate decarboxylation | Diagnosing PDHC deficiency; testing activators |
| Lactate dehydrogenase assay | Conversion of pyruvate to lactate | Evaluating anaerobic glycolysis |
| Pyruvate kinase activity assay | ADP or lactate production | Screening for PK inhibitors/activators |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identifying novel regulators of pyruvate metabolism |
| Metabolomics (LC-MS/GC-MS) | Intracellular levels of pyruvate and related metabolites | Quantifying metabolic changes in disease models |
| Isotope tracing (13C-pyruvate) | Labeling patterns in TCA intermediates | Tracing pyruvate fate in cells |
| Western blotting | Protein expression of PDHC subunits, PKM, LDHA | Validating CRISPR knockouts |
Metabolic Flux Analysis
Metabolic flux analysis using 13C-labeled substrates (e.g., 13C-glucose or 13C-pyruvate) allows quantification of pyruvate utilization through oxidative and fermentative pathways. This method measures the contribution of pyruvate to lactate, acetyl-CoA, and TCA cycle intermediates [1,5]. In rat hepatocytes, such analyses revealed the impact of pyruvate kinase inhibition on metabolic flux.
Enzyme Activity Assays
Enzyme activity assays for PDHC, PK, LDH, and PC are used to measure the catalytic capacity of pyruvate-metabolizing enzymes. PDHC activity can be measured spectrophotometrically by monitoring NADH production [1,3]. Carnitine stimulation of PDHC in isolated mitochondria was demonstrated using such assays. PK activity is measured by lactate production or ADP formation.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that are essential for growth or survival under conditions where pyruvate metabolism is perturbed. For example, screening in PDHA1-knockout cells can reveal synthetic lethal interactions. This approach is powerful for discovering novel regulators of pyruvate metabolic process.
Metabolomics and Isotope Tracing
Untargeted and targeted metabolomics quantify intracellular pyruvate and its derivatives (lactate, alanine, acetyl-CoA). Isotope tracing with 13C-pyruvate tracks its fate through metabolic networks [1,5]. These methods are essential for understanding how genetic perturbations alter pyruvate metabolism.
How CRISPR Can Be Used to Study GO:0006090 pyruvate metabolic process
Knockout
CRISPR knockout of genes involved in pyruvate metabolism (e.g., PDHA1, LDHA, PKM) creates isogenic cell lines to study loss-of-function phenotypes. For example, PDHA1 knockout cells exhibit reduced oxidative metabolism and increased lactate production. These models are valuable for dissecting metabolic dependencies and testing compensatory pathways.
Point Mutation
CRISPR point mutation introduces specific disease-associated mutations (e.g., in PDHA1 or PKLR) to study their effects on enzyme activity and metabolism. This approach allows precise modeling of genetic disorders such as PDHC deficiency or pyruvate kinase deficiency [3,5]. Point mutations can be introduced via homology-directed repair with donor templates.
Knock-in
CRISPR knock-in can insert tags (e.g., FLAG, GFP) or reporter genes into endogenous loci to track protein localization and expression. For pyruvate metabolism, knock-in of fluorescent tags into PDHA1 or MPC1 enables live-cell imaging of mitochondrial pyruvate carriers. Knock-in of patient mutations is also used to create disease models.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase expression of pyruvate-metabolizing enzymes to study gain-of-function effects. Overexpressing PDK1 inhibits PDHC and shifts metabolism toward glycolysis, mimicking cancer phenotypes. Overexpression of PC enhances gluconeogenesis in hepatocytes.
How EDITGENE Supports pyruvate metabolic process Research
Researchers studying pyruvate metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in pyruvate metabolism.
Contact EDITGENE today to design your custom CRISPR model for pyruvate metabolic process research.
Frequently Asked Questions About pyruvate metabolic process
What is pyruvate metabolic process?
Pyruvate metabolic process (GO:0006090) is the set of chemical reactions and pathways involving pyruvate, a key metabolite in energy production, including its conversion to acetyl-CoA, lactate, oxaloacetate, and alanine.
What genes are involved in pyruvate metabolic process?
Key genes include PDHA1, PDHB, DLAT, DLD, PDK1-4, PDP1, PKM, PKLR, LDHA, LDHB, PC, PCK1, PCK2, GPT, MPC1, and MPC2 [1,2,3,5].
What is the role of pyruvate dehydrogenase complex in pyruvate metabolism?
PDHC catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA, linking glycolysis to the TCA cycle. Its activity is regulated by PDKs and PDPs [1,3].
How is pyruvate metabolic process regulated?
It is regulated by reversible phosphorylation of PDHC by PDKs and PDPs, allosteric regulation of pyruvate kinase, and substrate availability such as pyruvate and carnitine [1,3,5].
What diseases are associated with pyruvate metabolic process?
Defects cause mitochondrial disorders, PDHC deficiency, lactic acidosis, and cancer metabolic reprogramming (Warburg effect) [3,6,8].
How can CRISPR be used to study pyruvate metabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes like PDHA1, LDHA, and PKM in isogenic cell lines [1,3,5].
What methods are used to study pyruvate metabolic process?
Common methods include 13C metabolic flux analysis, enzyme activity assays, metabolomics, isotope tracing, and CRISPR screening [1,3,5].
What is the Warburg effect in relation to pyruvate metabolism?
The Warburg effect is the shift of cancer cells toward lactate production from pyruvate even in the presence of oxygen, driven by LDHA and PKM2 [6,8].
What is the pyruvate dehydrogenase bypass?
It is an alternative pathway to produce acetyl-CoA from pyruvate without PDHC, found in some bacteria and lactic acid bacteria [6,7].
Why is pyruvate metabolism important for mitochondrial disorders?
Impaired pyruvate oxidation leads to energy failure and lactic acidosis, hallmark features of mitochondrial disorders such as PDHC deficiency [3,8].
Conclusion
Pyruvate metabolic process (GO:0006090) is a central metabolic pathway that connects glycolysis, the TCA cycle, and gluconeogenesis. Its dysregulation underlies mitochondrial disorders, cancer, and metabolic diseases. Understanding the genes and regulatory mechanisms involved is essential for developing targeted therapies. CRISPR-based models and advanced metabolic methods provide powerful tools to dissect this process and identify novel therapeutic targets.
References
- 1. Carter TC et al.. 1995. Effects of pyruvate on pyruvate dehydrogenase kinase of rat heart.. Mol Cell Biochem 149-150:71-5 PMID: 8569751
- 2. Sakagishi Y. 1995. [Alanine aminotransferase (ALT)].. Nihon Rinsho 53(5):1146-50 PMID: 7602770
- 3. Uziel G et al.. 1988. Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria.. Muscle Nerve 11(7):720-4 PMID: 3405240
- 5. Buc HA et al.. 1981. Metabolic consequences of pyruvate kinase inhibition by oxalate in intact rat hepatocytes.. Biochimie 63(7):595-602 PMID: 7284471
- 6. Kandler O. 1983. Carbohydrate metabolism in lactic acid bacteria.. Antonie Van Leeuwenhoek 49(3):209-24 PMID: 6354079
- 7. Mendz GL et al.. 1994. Pyruvate metabolism in Helicobacter pylori.. Arch Microbiol 162(3):187-92 PMID: 7979873
- 8. Przyrembel H. 1987. Therapy of mitochondrial disorders.. J Inherit Metab Dis 10 Suppl 1:129-46 PMID: 3119936
